Well, I could have made a massive profit by averaging down big time after my initial small purchase at 35c but somehow the pps dropped to as low as 4c without any negative clinical trial update, and then the pps rerated back to 15c based of significant clinical trial update but then I would have had to very pay big CGT gain.
Like I told you, I invest in biotech start-up for massive return including the "profit" from the GCT discount and will average down as somehow the market continue to give me the opportunity to despite the further positive fundamental from IMU.
No doubt, the drop on further positive fundamental the last 12 months has been very surprising, clearly IMU is still a traders stock but you honestly can't tell me you aren't surprised with how low the pps has drop after all the fundamental achieved in the last 12 months.
IMU Price at posting:
4.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)